Celtaxsys
Atlanta, US · Delaware corporation · 1 known investors
Biotech
Founders & leadership
ES
Eric SpringmanExecutive
SA
Sanjeev Ahuja, M.D.Executive
GD
Greg DuncanExecutive
WP
William P. ReddickExecutive
Board
MG
Maxim GorbachevBoard director
NV
Nicole VitulloBoard director
GB
MW
Michael W. MastersBoard director
HD
H. Daniel Perez, M.D.Board director
Investors · 1
Reported raises · per SEC filings
Form D private placements$21.6M disclosed across 1 round · 2015
▶$21.6MraisedJun 2015 · 8 investors · BiotechnologyRule 506(b)
▶$21.6MraisedJun 2015 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- H. Daniel Perez, M.D.Director
- Maxim GorbachevDirector
- Nicole VitulloDirector
- Eric SpringmanExecutive Officer
- Sanjeev Ahuja, M.D.Executive Officer
- Gerry BrunkDirector
- Greg DuncanExecutive Officer, Director
- William P. ReddickExecutive Officer
- Michael W. MastersDirector
- Offering amount
- $40M
- Amount sold
- $21.6M
- Sales commissions
- $1M
- Placement agents
- Livingston Securities, LLC
- First sale
- Jun 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Celtaxsys's investors?
- Celtaxsys's investors include Lumira Ventures.
- How much funding has Celtaxsys raised?
- Celtaxsys has disclosed $21.6M raised across 1 round.
- Where is Celtaxsys headquartered?
- Celtaxsys is headquartered in Atlanta, US.